LNSR LENSAR, Inc.
Healthcare$6.05-0.66%ClosedMarket Cap: $73.2M
As of 2026-05-26
Valuation
P/E (TTM)
—
PEG
—
P/B
3.01
P/S
1.28
EV/EBITDA
-7.85
DCF Value
$-48.39
FCF Yield
-16.6%
Div Yield
0.0%
Margins & Returns
Gross Margin
45.3%
Operating Margin
-28.7%
Net Margin
50.9%
ROE
-514.9%
ROA
44.4%
ROIC
-33.6%
Income Statement
Periods shown are fiscal year quarters (may differ from calendar year)
| Period | Revenue | Gross Margin | Operating Income | Net Income | EPS | Dividend |
|---|---|---|---|---|---|---|
| Q1 null | $13.4M | 47.5% | $2.2M | $36.3M | $— | — |
| Q4 null | $16.0M | 43.3% | $-4.9M | $-1.5M | $— | — |
| FY null | $58.4M | 46.4% | $-24.6M | $-34.3M | $— | — |
| Q3 null | $14.3M | 40.6% | $-7.6M | $-3.7M | $— | — |
| Q2 null | $13.9M | 50.4% | $-6.3M | $-1.8M | $— | — |
| Q1 null | $14.2M | 50.3% | $-5.8M | $-27.3M | $— | — |
| Q4 null | $16.7M | 42.5% | $-1.3M | $-18.7M | $— | — |
| FY null | $53.5M | 48.3% | $-10.7M | $-31.4M | $— | — |
| Q3 null | $13.5M | 46.3% | $-1.0M | $-1.5M | $— | — |
| Q2 null | $12.6M | 52.1% | $-1.6M | $-9.0M | $— | — |
| Q1 null | $10.6M | 50.9% | $-2.9M | $-2.2M | $— | — |
| Q4 2023 | $12.1M | 40.3% | $-3.0M | $-3.9M | $-0.35 | — |